| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $3.1M | +15.2% | -4.6% |
| SG&A Expense | $2.6M | -4.6% | -7.3% |
| Operating Income | -$5.7M | -5.2% | +5.9% |
| Net Income | -$5.7M | -4.0% | +2.7% |
| EPS (Basic) | -$0.03 | +0.0% | +0.0% |
| EPS (Diluted) | -$0.03 | +0.0% | +0.0% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $2.1M | +3.0% | -39.9% |
| Total Assets | $4.5M | +5.3% | +4.8% |
| Current Liabilities | $6.7M | -16.6% | -35.3% |
| Total Liabilities | $12.3M | -10.4% | +17.5% |
| Stockholders' Equity | -$7.8M | +17.5% | -26.4% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$10.1M | — | — |
| Financing Cash Flow | $9.9M | — | — |